CD86 and neoplasm: The correlation of CD86 and CD80 with clinical outcome in canine histiocytic disease has not been reported so far, however the expression of their receptor CTLA-4 on tumor cells is associated with a worse prognosis in other malignant tumors in dogs (16, 40, 41).